De novo lupus nephritis and belimumab

Rheumatology, Oxford Journals by Oxford University Press

Jan 26, 202214:39Science & Medicine

Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval...

Related Episodes

Continue listening to more episodes from Rheumatology, Oxford Journals.

BSR myositis guideline: What does this mean for patients?

Apr 1, 2022 - 15:17

How will patients be affected by the 2022 BSR guideline on the management of paediatric, adolescent and a...

BSR myositis guideline: What does this mean for patients?

Apr 1, 2022 - 15:17

How will patients be affected by the 2022 BSR guideline on the management of paediatric, adolescent and a...

BSR myositis guideline: Clinical updates

Mar 31, 2022 - 26:57

What do you need to know about the 2022 BSR guideline on the management of paediatric, adolescent and adu...

BSR myositis guideline: Clinical updates

Mar 31, 2022 - 26:57

What do you need to know about the 2022 BSR guideline on the management of paediatric, adolescent and adu...

Improving outcomes for hospitalised gout patients

Mar 16, 2022 - 13:38

Dr. Mark Russell (King's College, London, UK) joins Dr. Sean Gill to talk about improving outcomes for pa...

Improving outcomes for hospitalised gout patients

Mar 16, 2022 - 13:38

Dr. Mark Russell (King's College, London, UK) joins Dr. Sean Gill to talk about improving outcomes for pa...

Safety and clinical activity of atacicept in SLE

Mar 10, 2022 - 05:39

Prof. Daniel J. Wallace (Los Angeles, USA) joins Dr. Anastasia Madenidou to talk about safety and clinica...

Safety and clinical activity of atacicept in SLE

Mar 10, 2022 - 05:39

Prof. Daniel J. Wallace (Los Angeles, USA) joins Dr. Anastasia Madenidou to talk about safety and clinica...